NCT02071342

Brief Summary

The aim of our study is to evaluate the clinical outcomes at 30 days and 1 year (cardiac death, myocardial infarction, target lesion revascularization (TLR), target vessel revascularization (TVR), thrombosis of the device in patients who are undergoing angioplasty in myocardial infarction and in which bioabsorbable stent was implanted (BVS). Additionally, we will evaluate the acute recoil after implantation of bioabsorbable stents. A 24 months follow-up , by means of coronary angiography accompanied by QCA and assessment with intracoronary ultrasound (IVUS) and VH (virtual histology) is scheduled.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2013

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 2, 2014

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 25, 2014

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

February 25, 2014

Status Verified

February 1, 2014

Enrollment Period

1 year

First QC Date

January 2, 2014

Last Update Submit

February 23, 2014

Conditions

Keywords

acute myocardial infarctionbioresorbable vascular scaffoldpercutaneous coronary intervention

Outcome Measures

Primary Outcomes (1)

  • MACE (Death, MI, TLR and TVR)

    MACE at 30 days and 1 year (Death, MI, TLR and TVR) and thrombosis of the device in patients with acute coronary syndrome undergoing PCI with stenting bioresorbable

    One year after index procedure

Secondary Outcomes (1)

  • Acute stent Recoil

    Within ten minutes after scaffold implantation

Other Outcomes (1)

  • conformability

    immediately after implantation of the device

Study Arms (1)

acute coronary syndrome

patients with acute myocardial infarction who are undergoing coronary angioplasty. MACE at 30 days and 1 year will be assessed . The acute recoil after implantation of bioabsorbable stents will also be assessed

Procedure: angioplasty

Interventions

angioplastyPROCEDURE

patients with acute coronary syndrome and coronary angioplasty with bioresorbable vascular scaffold.

Also known as: bioabsorbable everolimus-eluting coronary stent, everolimus-eluting bioresorbable vascular scaffold (BVS)
acute coronary syndrome

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with acute coronary syndrome who are undergoing coronary angioplasty.

You may qualify if:

  • patients older than 18 years with acute coronary syndrome (STEMI and NSTEMI) will be enrolled

You may not qualify if:

  • patients with these characteristics will be excluded: cardiogenic shock (defined as systolic blood pressure less than 80 mmHg for more than 30 minutes or the need for compressors or intravenous-intraaortic balloon counterpulsation), history of bleeding diathesis, history of leukopenia , thrombocytopenia, or severe hepatic or renal dysfunction, a non-cardiac disease associated with a life expectancy of less than one year, participating in another study, or not able to give informed consent due to a prolonged resuscitation cardiopulmonary.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Division of interventional cardiology, Umberto I Hospital

Frosinone, Frosinone, 030100, Italy

RECRUITING

MeSH Terms

Conditions

Congenital Abnormalities

Interventions

Angioplasty

Condition Hierarchy (Ancestors)

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

CatheterizationTherapeuticsEndovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical ProceduresInvestigative Techniques

Study Officials

  • Maurizio Menichelli, MD

    Division of Cardiology "Fabrizio Spaziani" Hospital Frosinone, Italy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Maurizio Menichelli, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director Division of Cardiology

Study Record Dates

First Submitted

January 2, 2014

First Posted

February 25, 2014

Study Start

September 1, 2013

Primary Completion

September 1, 2014

Study Completion

September 1, 2015

Last Updated

February 25, 2014

Record last verified: 2014-02

Locations